Alterity Therapeutics Stock Forecast 2022, 2023, 2024, 2025

[Average Rating: 5]

The stock of Alterity Therapeutics has increased 20% in the past month. Alterity Therapeutics stock forecasts for 2022, 2023, 2024, and 2025 should therefore be examined. Alterity Therapeutics Stock Price Target in the future is discussed in the following article.

Before looking at Alterity Therapeutics stock forecast, we must first examine the company’s stock price history & market capitalization.

About Alterity Therapeutics Stock

In Australia, Alterity Therapeutics Limited conducts research and development on therapeutic drugs to treat conditions such as Alzheimer’s disease, Huntington disease, Parkinson’s disease, and other neurological disorders.

ATH434 has completed a Phase I clinical trial for Parkinson’s disease. It is the company’s lead drug candidate. 

Alterity Therapeutics Stock
Market Cap
48.043M
Beta (5Y Monthly)
1.02
PE Ratio (TTM)
N/A
EPS (TTM)
-0.3600
Earnings Date
N/A
Alterity Therapeutics Forecast

Alterity Therapeutics Forecast 2022

Date
Stock Price
February 2022
 0.0668
Alterity Therapeutics Ltd. Stock Price Forecast for 2022
Alterity Therapeutics Stock Forecast
Alterity Therapeutics Stock Forecast

Alterity Therapeutics Forecast 2023

Date
Stock Price
January 2023
 0.0362
February 2023
 0.0581
Alterity Therapeutics Ltd. Stock Price Forecast for 2023
Alterity Therapeutics Stock Forecast 2023

Alterity Therapeutics Forecast 2024

Date
Stock Price
January 2024
 0.0256
February 2024
 0.0488
Alterity Therapeutics Ltd. Stock Price Forecast for 2024

Alterity Therapeutics Forecast 2025

Date
Stock Price
January 2025
 0.0218
Alterity Therapeutics Ltd. Stock Price Forecast for 2025

Leave a Reply

* Our share forecasts and predictions are made by Machine Learning & Ai, and shouldn't been used for financial decisions. We can't guarantee any profit.